4//SEC Filing
Southpoint GP, LP 4
Accession 0001012975-25-000793
CIK 0001211583other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 8:42 PM ET
Size
14.7 KB
Accession
0001012975-25-000793
Insider Transaction Report
Form 4
Southpoint GP, LP
10% Owner
Transactions
- Sale
Common Stock
2025-11-17$8.79/sh−85,918$755,193→ 3,764,082 total(indirect: See Footnote) - Sale
Common Stock
2025-11-14$8.00/sh−160,100$1,280,432→ 3,850,000 total(indirect: See Footnote)
Southpoint GP, LLC
10% Owner
Transactions
- Sale
Common Stock
2025-11-14$8.00/sh−160,100$1,280,432→ 3,850,000 total(indirect: See Footnote) - Sale
Common Stock
2025-11-17$8.79/sh−85,918$755,193→ 3,764,082 total(indirect: See Footnote)
Clark John Smith II
10% Owner
Transactions
- Sale
Common Stock
2025-11-14$8.00/sh−160,100$1,280,432→ 3,850,000 total(indirect: See Footnote) - Sale
Common Stock
2025-11-17$8.79/sh−85,918$755,193→ 3,764,082 total(indirect: See Footnote)
Southpoint Capital Advisors LP
10% Owner
Transactions
- Sale
Common Stock
2025-11-14$8.00/sh−160,100$1,280,432→ 3,850,000 total(indirect: See Footnote) - Sale
Common Stock
2025-11-17$8.79/sh−85,918$755,193→ 3,764,082 total(indirect: See Footnote)
Southpoint Capital Advisors LLC
10% Owner
Transactions
- Sale
Common Stock
2025-11-14$8.00/sh−160,100$1,280,432→ 3,850,000 total(indirect: See Footnote) - Sale
Common Stock
2025-11-17$8.79/sh−85,918$755,193→ 3,764,082 total(indirect: See Footnote)
Footnotes (3)
- [F1]The securities are directly held by Southpoint Master Fund, LP for which Southpoint Capital Advisors LP serves as the investment manager and Southpoint GP, LP serves as the general partner. Southpoint Capital Advisors LLC serves as the general partner of Southpoint Capital Advisors LP and Southpoint GP, LLC serves as the general partner of Southpoint GP, LP. John S. Clark II serves as managing member of both Southpoint Capital Advisors LLC and Southpoint GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.
- [F2]The transaction was executed in multiple trades at prices ranging from $7.86 to $8.15. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
- [F3]The transaction was executed in multiple trades at prices ranging from $8.75 to $8.97. The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001378376
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 8:42 PM ET
- Size
- 14.7 KB